National Grid, Nike & PepsiCo: This Week in Sustainability

After spending a 13-year tenure at GSK, Claire Lund has announced her appointment as Chief Sustainability Officer at National Grid.
Her position at GSK has been filled by Adele Cheli, who has taken over as Global VP Sustainability.
Claire’s new role builds upon her more than 20-year career in energy, procurement and sustainability.
Global circularity rates fell to 6.9% from 7.2% in 2025, according to the Circularity Gap Report.
This demonstrates a need for companies to design products for recyclability and reusability, in order to contribute to the circular economy.
Join sustainability leaders at Sustainability LIVE: The US Summit on 21-22 April for the Circularity & Recycling panel.
For elite athletes, every tiny detail counts. A millimetre could mean joy or heartbreak: data is the difference between victory and defeat.
This truth is compelling when it comes to competition and training kit. Which is why Nike has combined cutting-edge manufacturing with daring design to produce kits for the FIFA World Cup 2026 that are “light, unrestrictive and comfortable” – and setting new sustainability standards.
Janett Nichol, VP, Apparel & Advanced Digital Creation Studio Innovation, Nike, says: “Nike exists to make athletes better and our breakthrough Aero-FIT technology delivers the future of our industry-defining apparel innovation in both elite performance and sustainability at scale.”
World Water Day, held on 22 March every year, focuses on the importance of fresh, safe water for global communities.
As part of World Water Day 2026, PepsiCo has announced that it has achieved two of its 2025 water goals.
These are part of its wider sustainability framework, pep+ (PepsiCo Positive), where it aims to put sustainability at the centre of its business strategy.
Eli Lilly stands as a pharmaceutical industry heavyweight with a workforce of more than 50,000 employees across the globe.
The company has built its reputation through the development and manufacture of treatments spanning diabetes, obesity, oncology and immunology.
The organisation has now released its 2025 Year in Review, detailing the financial achievements and sustainability initiatives that defined its operations over the past 12 months.









